ReviewCureus2025
Electron Microscopy in Renal Biopsy Interpretation: When and Why It Still Matters.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Semi-automated reconstruction of glomerular architecture from 3D confocal microscopy data.bioRxiv : the preprint server for biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Electron microscopy (EM) remains an indispensable tool in renal pathology, providing ultrastructural details that complement light microscopy (LM) and immunofluorescence (IF) in the diagnosis of glomerular diseases. This review outlines the diagnostic role of EM across major categories of glomerular pathology, emphasizing its value in confirming and refining histopathological diagnoses. In membranous nephropathy, EM visualizes subepithelial electron-dense deposits and tracks disease progression through glomerular basement membrane (GBM) remodeling. In immune complex-mediated glomerulonephritides, such as IgA nephropathy and lupus nephritis, EM localizes deposits to mesangial, subendothelial, or subepithelial regions, facilitating accurate classification. For C3 glomerulopathies, EM distinguishes dense deposit disease from C3 glomerulonephritis by revealing unique ribbon-like intramembranous densities. In hereditary nephritides like Alport syndrome and thin basement membrane nephropathy, EM provides pathognomonic findings of GBM lamellation and thinning that often precede or guide genetic testing. Additionally, EM identifies organized deposits in fibrillary and immunotactoid glomerulopathies and helps differentiate diabetic glomerulosclerosis from mimickers through assessment of GBM thickening and matrix expansion. Despite advances in molecular diagnostics, EM remains essential for identifying subtle ultrastructural changes, validating immunopathologic interpretations, and guiding clinical management. This article reinforces EM's continued relevance in an era of expanding genetic and serologic tools.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.